Léčba Waldenströmovy makroglobulinemie - zkušenosti jednoho pracoviště

Title in English Treatment of Waldenström macroglobulinaemia--the experience of one centre
Authors

ADAM Zdeněk POUR Luděk KREJČÍ Marta KOŘÍSTEK Zdeněk NAVRÁTIL Milan KŘIVANOVÁ Andrea ZAHRADOVÁ Lenka HÁJEK Roman

Year of publication 2009
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords Waldenström macroglobulinaemia;
Description Waldenström macroglobulinaemia (WM) is a disease the incidence of which is approximately 10 times lower than that of multiple myeloma. The incidence of WM is reported to be respectively 0.34 per 100,000 men and 0.7 per 100,000 women. It is one of the less aggressive lymphoproliferative diseases in which therapy is indicated only when the disease symptoms start to manifest. We present a retrospective analysis of patients with the symptomatic form of WM who were treated with chemotherapy in our centre over the last 9 years
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info